Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: esrd here for kidney transplant major surgical or invasive procedure: renal transplant history of present illness: 60f w/esrd polycystic kidney disease, on dialysis since , presenting for kidney transplant. she was recently re-activated on the transplant list after a cardiac catheterization was normal. information obtained from the patient with yes/no questions and one-word answers, as she is aphasic after a cva, as well as from her son and husband. she has been in her usual state of health recently. she and her family deny any fever, chills, cough, sob, chest pain, trouble breathing, abdominal pain, nausea, vomiting, diarrhea, fatigue, change in bowel or bladder habits, weakness, numbness, or altered mental status. past medical history: cva brain aneurysm, clipped at ; htn; h/o seizure after dialysis, none in past 2 years psh: multiple access procedures; aneurysm clipping social history: social: lives with husband. is very supportive and is with her now, and will be available after surgery. family history: family: father died of kidney problems. mother died of cancer. physical exam: vitals: t 97.6, hr 78, bp 121/77, rr 20, o2 97ra gen: alert and oriented x3, nad, answers appropriately with yes/no or one-word answers cv: rrr, no murmur resp: cta bilaterally, good respiratory effort abd: obese, soft, nt, nd, +bs extr: warm, well-perfused, 2+ pulses dre: no gross blood pertinent results: on admission: wbc-6.1 rbc-4.45 hgb-13.7 hct-39.2 mcv-88 mch-30.8 mchc-35.0 rdw-14.2 plt ct-127* pt-13.6* ptt-25.0 inr(pt)-1.2* urean-65* creat-12.9*# na-146* k-4.9 cl-106 hco3-24 angap-21* alt-32 ast-20 albumin-4.4 calcium-10.5* phos-5.4* mg-2.6 phenytoin-<0.6* at discharge: wbc-5.1 rbc-3.48* hgb-10.6* hct-30.8* mcv-88 mch-30.4 mchc-34.4 rdw-15.1 plt ct-151 pt-11.8 ptt-30.7 inr(pt)-1.0 glucose-109* urean-26* creat-6.1*# na-139 k-4.1 cl-101 hco3-24 angap-18 calcium-8.8 phos-4.8* mg-2.0 tacrofk-7.2 brief hospital course: 60 y/o female with espd secondary to polycystic kidney disease who now undergoes a renal transplant right iliac fossa. intra- abdominal 6-french double-j stent. she was taken to the or with dr . once the kidney was placed, the kidney pinked up and immediately began making urine, however the kidnbey was placed intra-peritoneally as the patient had previus surgery with placement of a vp shunt so there were dense adhesions. also of note, the bladder was difficult to identify as there was extensive amount of adipose tissue in the midline and the bladder was very, very deep in the pelvis. patient tolerated the procedure and she was transferred to pavcu in stable condition. post-operatively the urine output was noted to be approximately 80-100 cc daily until about post op day 9 when output increased to about 400 cc daily. the wound started having large volume drainage, and a specimen was sent for creatinine, however this did not appear to be urine. ultrasounds of the kidneys have demonstrated normal waveforms with some perinephric fluid. the wound was opened and a vac placed on pod 6 as the dressing changes were multiple daily and skin was erythemotous from the drainage. output since the vac placement has been 100-600 cc daily of sero-sanguinous drainage. she received 2 days of ancef for the erythema but this was d/c'd as wound looked improved with the vac. the patient was dialyzed on pod 1 for potassium elevation and has remained on routine hemodialysis since that time using a tunneled dialysis catheter. the dilantin she was taking prior to transplant was transitioned to keppra due to the effects of dilantin on prograf levels. the transition was made early. immunosuppression was started peri-operatively. she received 5 doses af atg for delayed graft function. mmf was started pre-op and prograf levels were dosed by level. the patient underwent transplant kidney biopsy on . results of biopsy reported as atn, c4d staining is negative. as there is no evidence of rejection the patient can be discharged with close follow up patient was screened and accepted for rehab for mobility issues and help with vac maintenance, hemodialysis and medication teaching. medications on admission: nephro caps, calcium acetate, metoprolol 50''', dilantin er 100''' discharge medications: 1. levetiracetam 500 mg tablet sig: one (1) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 2. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 3. sulfamethoxazole-trimethoprim 400-80 mg tablet sig: one (1) tablet po daily (daily). 4. nystatin 100,000 unit/ml suspension sig: five (5) ml po qid (4 times a day). 5. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 6. valganciclovir 450 mg tablet sig: one (1) tablet po 2x/week (tu,fr). 7. hydromorphone 2 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed for pain. disp:*50 tablet(s)* refills:*0* 8. famotidine 20 mg tablet sig: one (1) tablet po q24h (every 24 hours). 9. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po daily (daily). 10. calcium acetate 667 mg capsule sig: two (2) capsule po tid w/meals (3 times a day with meals). 11. metoprolol tartrate 50 mg tablet sig: one (1) tablet po tid (3 times a day). 12. amlodipine 5 mg tablet sig: one (1) tablet po daily (daily). 13. tacrolimus 5 mg capsule sig: one (1) capsule po twice a day: levels q monday and thursday. do not change dose unless directed by transplant clinic. discharge disposition: extended care facility: northeast - discharge diagnosis: esrd s/p renal transplant delayed graft function seizure disorder discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - requires assistance or aid (walker or cane). discharge instructions: please call the transplant office if patient has any of the following: fever(101 or greater), chills, nausea, vomiting, diarrhea, inability to take any of her medications, increased abdominal pain or distension, abdominal wound smells foul or drainage increases, weight gain of 3 pounds in a day or any questions patient to have blood drawn every monday and thursday, slips included with discharge paperwork. labs to be couriered to dialysis to be performed q monday, weds, friday using tunneled dialysis line vac to be changed q 3 days monitor i&os and send copy with patient followup instructions: provider: , transplant social work date/time: 10:30 , , provider: , md phone: date/time: 1:20, , , provider: , md phone: date/time: 9:00 , , procedure: hemodialysis closed [percutaneous] [needle] biopsy of kidney other kidney transplantation other operations on lacrimal gland transplant from cadaver diagnoses: hyperpotassemia end stage renal disease renal dialysis status acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peritoneal adhesions (postoperative) (postinfection) other late effects of cerebrovascular disease late effects of cerebrovascular disease, hemiplegia affecting unspecified side epilepsy, unspecified, without mention of intractable epilepsy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, aphasia complications of transplanted kidney polycystic kidney, autosomal dominant 

Answer: The patient is high likely exposed to